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The protein kinase Mps1 and p53 both function in
centrosome duplication and the spindle cell-cycle
checkpoint. Defects in these functions can be potent
sources of genomic instability by allowing mitosis to
proceed with aberrant mitotic spindles.
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Genomic instability is characteristic of cancer cells, and
promotes the accumulation of genetic lesions that con-
tribute to their neoplastic progression. There are at least
two general mechanisms by which cells exhibiting
genomic instability can depart from the diploid state. One
involves DNA damage from high levels of translocations,
gene amplification or other chromosomal anomalies. The
other involves chromosome segregation errors, probably
arising from defective mitotic spindles, leading to exten-
sive aneuploidy or even tetraploidy. A compelling argu-
ment has been made that cells with defective checkpoint
controls on the cell cycle are unable to respond to DNA
damage or spindle defects, thereby allowing the cells to
proceed through the cell cycle while retaining the damage,
possibly in consequence entering an aberrant state [1,2].
Checkpoint controls normally ensure that, as the cell cycle
progresses, one process — DNA replication, for example
— is successfully completed before a succeeding, incom-
patible one is begun. The tumor suppressor gene p53
illustrates the importance of checkpoint controls in main-
taining genomic integrity. The p53 protein functions in
two cellular responses to DNA damage: the checkpoint
that reversibly arrests the cell cycle at the G1/S transition
to allow time for relatively mild DNA damage to be
repaired before the genomic DNA is replicated; and the
induction of cell death, or apoptosis, that occurs in the face
of extensive DNA damage (reviewed in [1–3]). In fact,
p53 has been so prominent in the analysis of the defective
cell-cycle controls observed in cancer cells that it was
named Science’s 1993 ‘molecule of the year’.
The initial sources of DNA damage or spindle malfunction
that can lead to genetic lesions in the absence of check-
point controls are not entirely known, but the damage
could easily arise either from intrinsic errors in cellular
processes or from environmental insult. Cellular damage
and the failure to respond appropriately to the damage has
been observed upon loss of function in an emerging class
of cell-cycle regulators. These regulatory molecules have
dual roles in cell-cycle progression and checkpoint function
[4]. Generally, the two roles of these molecules are related,
in that the molecule is involved in carrying out a process
for which it also mediates the quality control via its check-
point function. An excellent example is DNA polymerase e
in the budding yeast Saccharomyces cerevisiae, which is
clearly required for DNA synthesis, but has a separable
function in triggering the arrest of mitosis in response to
incomplete DNA synthesis [5]. Clearly, defects in this class
of cell-cycle regulators could be a potent source of genomic
instability by both creating damage and then failing to
respond to the damage.
Recent results have shown that the p53 can act as a dual
function cell-cycle regulator. The surprising result, given
p53’s known activity in the G1 DNA-damage checkpoint,
is that the newly defined roles of p53 are in mitotic
spindle assembly [6] and in the spindle checkpoint that
leads to a cell-cycle arrest in response to aberrant mitotic
spindles [7]. The spindle checkpoint function was assayed
by treating mouse embryonic fibroblast (MEF) cells with
the microtubule poison, nocodazole. This drug causes
defects in the spindle and blocks mitotic progression by
triggering the spindle checkpoint, so that wild-type cells
arrest with a post-S-phase DNA content. MEF cells
derived from p53-null mutant mice, however, inappropri-
ately reinitiate DNA synthesis in the presence of nocoda-
zole, showing that the spindle checkpoint fails to function
in these cells and implying that p53 is an essential compo-
nent of the checkpoint machinery [7].
A separate study of MEF cells from p53-null mice has
shown that they have a defect in centrosome duplication
[6]. The cells appear to over-produce centrosomes, as
shown by the appearance of several foci of g tubulin stain-
ing, instead of the expected one or two, according to the
cell-cycle stage. The additional foci may represent extra
centrosomes, partially assembled centrosomes or centroso-
mal fragments. Nonetheless, the cells are clearly aberrant
and their defective centrosome assembly has clearly gen-
erated multipolar spindles. The origin of these multipolar
spindles was addressed using synchronized cells to show
that the multiple g tubulin foci could arise from a single
defective round of centrosome duplication in G1 phase.
This observation suggests that the multipolar spindles do
not result from the mis-segregation of the centrosomes,
but rather from a defect in centrosome duplication. Taken
together, these two studies suggest that MEF cells lacking
p53 often fail in centrosome assembly and go on to form
aberrant spindles that may be allowed to mis-segregate
chromosomes because the spindle assembly checkpoint is
defective as well. Such a model implicates p53 in mainte-
nance of the genome at the fundamental level of control-
ling centrosome duplication, an early stage of spindle
assembly, and in the spindle checkpoint’s assessment of
the functionality of the spindle.
Both centrosome duplication and the spindle checkpoint
have been studied in S. cerevisiae. The morphology of the
yeast equivalent of the centrosome — the spindle pole
body — and its duplication in G1 phase have been well
described. Furthermore, several genes which are required
for the proper execution of spindle-pole duplication 
have been identified by mutation (reviewed in [8,9]).
Conditional loss of function in any one of these genes
leads to failure in spindle pole body duplication, leaving
the cell with a single functional spindle pole body and in
some cases with a defective second spindle pole body. In
general, these cells with single spindle pole bodies con-
tinue with DNA synthesis and bud growth, eventually
coming to a mitotic arrest with a monopolar spindle.
The mitotic arrest observed in yeast cells with monopolar
spindles is induced through the spindle checkpoint [10,11].
Several yeast genes involved in this checkpoint have been
identified by mutations that cause cells to be unable to
arrest in the presence of microtubule poisons, and the
function of the products of these genes in a signaling
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A schematic representation of centrosome duplication in a mouse cell
(top) and a budding yeast cell (bottom), showing the defects in
centrosome duplication that result from a loss of p53 or Mps1 activity
and the second function both these proteins have in blocking cell-cycle
progression if there is a defect in the mitotic spindle. (During the
budding yeast cell cycle, the ‘satellite’ appears on the cytoplasmic face
of the half bridge during spindle pole body duplication, and is thought
to be the precursor of the new spindle pole body [9].)
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pathway is emerging [12]. These genes are required for
cells to arrest in mitosis after failed spindle pole body
duplication. The arrest is transient, however, as cells con-
taining monopolar spindles have been observed to carry
out cytokinesis and reinitiate DNA synthesis at the non-
permissive temperature, thus acquiring twice the ploidy of
the starting strain [13]. 
This phenomenon of a transient mitotic arrest in cells con-
taining a monopolar spindle may result from attenuation
of the checkpoint pathway signal, or from fulfillment by
the monopolar spindle of the criteria for release from the
arrest state, which may be kinetochore attachment [12].
Regardless of the mechanism, these cells carry out a
monopolar mitosis, demonstrating that cells defective in
spindle pole body duplication can exhibit an increase in
ploidy, one type of genomic instability. This situation is a
variation on the initial hypothesis that genomic instability
results from defective checkpoint control [1]. In this case,
a functioning checkpoint eventually fails by allowing the
cell cycle to proceed despite the presence in the cell of an
aberrant structure.
Studies of the yeast monopolar spindle mutants have not
only offered insights into cellular pathways to increased
ploidy, but have also led to the identification of the MPS1
gene, which acts both in spindle pole body duplication
and the spindle checkpoint, and encodes a protein kinase
[10,11,13]. This dual requirement for the Mps1 kinase is
similar to that for p53 in centrosome duplication and the
spindle checkpoint, though the roles of these two genes in
spindle pole duplication are different (Fig. 1). Whereas
the loss of p53 leads to over-replication or aberrant assem-
bly of centrosomes [6], the loss of Mps1 activity leads to a
block in spindle pole duplication [13]. 
Mps1 and p53 do, however, have comparable roles in the
spindle checkpoint. Phenotypic analyses of cells lacking
p53 [6] or active Mps1 [10] show that both proteins are
required for the arrest elicited by nocodazole treatment.
Although there are some phenotypic differences between
cells lacking p53 or active Mps1, it appears that a regula-
tory link between centrosome duplication and the spindle
assembly checkpoint may be general feature in eukary-
otes. Defects in the genes that link these two pathways
can be potent sources of genomic instability, because their
failure to function not only leads to defects in spindle
assembly, but also leaves the cell unable to respond appro-
priately to the defective spindle.
The p53 protein is nonfunctional in cells that give rise to
many different types of cancer, but the contributions of
defects in centrosome duplication and the spindle check-
point to genomic instability in these cells remain to be
determined. Despite the potential significance of these
pathways in the maintenance of ploidy, they are largely
uncharacterized in mammalian cells. The molecules that
work with p53 in its centrosome assembly and spindle
checkpoint functions need to be identified. Furthermore,
the p53-independent pathways that allow some cell lines
lacking p53 to arrest in the presence of nocodazole remain
to be elucidated [7]. Continued analysis in yeast of spindle
pole duplication, the spindle checkpoint pathway and the
intersection of these pathways will augment our under-
standing of similar pathways in mammalian cells.
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